On December 27, the Food and Drug Administration (TFDA), Ministry of Health and Welfare of the Republic of China, issued a Class 1 drug recall alert concerning “Cosar F.C. Tablets 50 mg,” a therapeutic agent prescribed for hypertension and diabetic nephropathy manufactured by Shou Yuan Chemical Pharmaceutical Co., Ltd. Following manufacturer disclosures that active pharmaceutical ingredient (API) lots contained impurities, the manufacturer initiated a voluntary recall after safety evaluations.
Recalled Drug Basic Information
- Product Name: Cosar F.C. Tablets 50 mg (脈莎平膜衣錠 50 毫克).
- Indications: Hypertension, treatment of diabetic nephropathy in patients with Type 2 diabetes.
- Active Ingredient: LOSARTAN POTASSIUM.
- Drug License Number: MOHW/DOH Drug Manufacturing License No. 055950.
- Batch / Lot Numbers: 511193, 601083, 601233, 601243, 606193, 607023, 607033, 609173, 610013, 610023, and 702043.
- License Holder: Shou Yuan Chemical Pharmaceutical Co., Ltd.
- Product Reference Photo:

Drug Recall Notice Details
- Recall Classification[1]: Class 1.
- Dispatch Order Number: December 27, 2018, FDA Drug No. 1071411172 (TFDA Medicinal Products Division).
- Dispatch Date: December 27, 2018.
- Publication Date: December 27, 2018.
- Reason for Recall: Voluntary manufacturer notification that active pharmaceutical ingredients (API) used in the specified product lots contained the impurity N-Nitrosodiethylamine (NDEA).
Further Reading
Support Independent Perspectives & In-Depth Insights
Every thoughtful analysis and candid critique comes from our dedication to truth and quality. We choose not to follow sensational algorithms or clickbait headlines.
Sustaining independent research requires reader support. Make a one-time or monthly contribution, securely processed by Google.
Payments secured by Google · Manage or cancel anytime in your Google Account


Comments